Newborn screening for Duchenne muscular dystrophy

Viewing 20 posts - 1 through 20 (of 42 total)
  • #135111
    Newborn screening for Duchenne muscular dystrophy

    Hi everyone,

    This Monday 25 July, 2pm to 3.30pm, we’ll be joined on Talk MD by experts including Professor Francesco Muntoni from Great Ormond Street Hospital and Rachel Salmon, Neuromuscular Care Advisor, for an online discussion on newborn screening for Duchenne muscular dystrophy.

    The National Screening Committee is currently not recommending a newborn screening programme for the condition. However, more potential treatments on the horizon and improvements in clinical care, it’s essential that work begins to ensure a programme of screening is available in the near future.

    We hope you’ll be able to join us to put your questions. However, if you won’t be able to follow the discussion on Monday please put any burning questions below and we’ll make sure they’re answered!

    Thanks,

    Peter

    Muscular Dystrophy UK staff member

    Alexa Follen
    Keymaster
    Posts: 32
    Joined: 12/05/2015
    #135376
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Hi everyone,

    Thanks for joining this Duchenne Dialogue on newborn screening for Duchenne muscular dystrophy.

    A special welcome to:

    • Professor Francesco Muntoni, Great Ormond Street Hospital
    • Rachel Salmon, Neuromuscular Care Advisor and former newborn screening nurse in Wales
    • Chris and Jeanette George, whose son, Alex, was diagnosed through the former newborn screening programme in Wales
    • Annie Kennedy, Senior Vice-President – Legislation and Public Policy, Parent Project Muscular Dystrophy

    Over the next hour or so, we’ll be discussing the benefits of screening for Duchenne, difficulties that can arise and the challenges that need to be overcome to get National Screening Committee approval for a screening programme.

    MDUK will be using some of the discussions and feedback as a basis for a response to the NSC’s current consultation on screening for Duchenne, which closes 15 August.

    For individuals with Duchenne, parents and family members who may be joining us, please feel free to contribute and ask questions at any point.

    Similarly to our experts, we’d like the discussion to be free flowing so please do come in with additional comments or with questions to one another.

    Muscular Dystrophy UK staff member

    Alexa Follen
    Keymaster
    Posts: 32
    Joined: 12/05/2015
    #135377
    Reply To: Newborn screening for Duchenne muscular dystrophy

    If we could start with Professor Muntoni –

    What would you say are the benefits of newborn screening from a clinical point of view?

    Muscular Dystrophy UK staff member

    Alexa Follen
    Keymaster
    Posts: 32
    Joined: 12/05/2015
    #135379
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Good adfternoon, just to say I am on line. Francesco Muntoni

    Professor Francesco Muntoni, Director, Dubowitz Neuromuscular Centre, Great Ormond Street Hospital

    Professor Francesco Muntoni
    Participant
    Posts: 0
    Joined: 05/05/2016
    #135380
    Reply To: Newborn screening for Duchenne muscular dystrophy

    The main benefit from a newborn screening would be:
    a. early genetic counselling for families
    b. early recognition of specific DMD issues relevant for management.
    c. the access to experimental therapies that are now becoming available for DMD (firs drug ataluren, last week).

    Professor Francesco Muntoni, Director, Dubowitz Neuromuscular Centre, Great Ormond Street Hospital

    Professor Francesco Muntoni
    Participant
    Posts: 0
    Joined: 05/05/2016
    #135381
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Thanks Francesco.

    Welcome also to Chris and Jeanette George who are joining us from Cardiff, and whose child was diagnosed through newborn screening in Wales, which was withdrawn in 2011.

    I wondered if you could say a bit about your experience of the newborn screening programme in Wales?

    We all know there is no good time to receive a diagnosis, but did the timing of the diagnosis – a few weeks after Alex’s birth – affect the way you subsequently managed his condition, or your planning ahead as a family?

    Muscular Dystrophy UK staff member

    Alexa Follen
    Keymaster
    Posts: 32
    Joined: 12/05/2015
    #135383
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Of the various issues to be considered in favour of newborn screening, it is important to recognise those that are unique for DMD, and not generic to any other genetic condition. So while there are specific issues that we acknolwedge would be of general importance for DMD (and other genetic conditions), it is important to focus on the DMD specific reasons. The initation of experimental therapies is one; also for the standards of care, the mean age of diagnosis is ~ 4.5 so many children lose the optimal timing for initating corticosteroid therapy hence lose the optimal window of opportunity to start early steroids, which is a recommended standard of care

    Professor Francesco Muntoni, Director, Dubowitz Neuromuscular Centre, Great Ormond Street Hospital

    Professor Francesco Muntoni
    Participant
    Posts: 0
    Joined: 05/05/2016
    #135384
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Hello all,

    Happy to participate with this discussion.

    Alex was diagnosed at 11 weeks on the basis of the heel prick test for which we gave consent.
    We have two older children who were OK and Alex was planned as the ‘last one’!

    He has a spontaneous mutation (deletion 3-7).

    After the diagnosis we had a few immediated considerations;
    1) mum decided to go back to work part time,
    2) stopped further investment in our home because we realised that Alex’ needs would probably require us to move
    3) financial planning
    4) for Alex, early start on vitamin D supplementation and it enabled us to have early discussions with clinicians and healthcare professionals (including Rachel) (e.g. annual flu jab, night splints, hospital appointments have become the ‘normal’)
    5) Deliberately steered Alex’ hobbies towards arts/crafts and swimming as opposed to those sports that cause physical trauma. No trampolines or swimming.
    6) Awareness of his condition at all phases of pre-school / school to date (including visits from occupational therapy.

    Chris and Jeanette George
    Participant
    Posts: 0
    Joined: 25/07/2016
    #135385
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Sorry – point 5 in our list should’ve been “no trampolining or scootering”. We find swimming helps him tremendously.

    Chris and Jeanette George
    Participant
    Posts: 0
    Joined: 25/07/2016
    #135386
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Thanks Francesco. One of the issues that came up with the NSC’s recent consultation document is a lack of clinical consensus on when to initiate best standards of care. Would you say that this is a fair comment, or is there a consensus around starting at a particular age that the NSC should be aware of?

    Muscular Dystrophy UK staff member

    Alexa Follen
    Keymaster
    Posts: 32
    Joined: 12/05/2015
    #135387
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Of the various issues to be considered in favour of newborn screening, it is important to recognise those that are unique for DMD, and not generic to any other genetic condition. So while there are specific issues that we acknolwedge would be of general importance for DMD (and other genetic conditions), it is important to focus on the DMD specific reasons. The initation of experimental therapies is one; also for the standards of care, the mean age of diagnosis is ~ 4.5 so many children lose the optimal timing for initating corticosteroid therapy hence lose the optimal window of opportunity to start early steroids, which is a recommended standard of care

    Thanks Francesco. One of the issues that came up with the NSC’s recent consultation document is a lack of clinical consensus on when to initiate best standards of care. Would you say that this is a fair comment, or is there a consensus around starting at a particular age that the NSC should be aware of?

    Muscular Dystrophy UK staff member

    Alexa Follen
    Keymaster
    Posts: 32
    Joined: 12/05/2015
    #135388
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Hello all,

    Happy to participate with this discussion.

    Alex was diagnosed at 11 weeks on the basis of the heel prick test for which we gave consent.
    We have two older children who were OK and Alex was planned as the ‘last one’!

    He has a spontaneous mutation (deletion 3-7).

    After the diagnosis we had a few immediated considerations;
    1) mum decided to go back to work part time,
    2) stopped further investment in our home because we realised that Alex’ needs would probably require us to move
    3) financial planning
    4) for Alex, early start on vitamin D supplementation and it enabled us to have early discussions with clinicians and healthcare professionals (including Rachel) (e.g. annual flu jab, night splints, hospital appointments have become the ‘normal’)
    5) Deliberately steered Alex’ hobbies towards arts/crafts and swimming as opposed to those sports that cause physical trauma. No trampolines or swimming.
    6) Awareness of his condition at all phases of pre-school / school to date (including visits from occupational therapy.

    Thanks for sharing this Chris and Jeanette. Based on your experience in Cardiff, would you both support UK wide screening for Duchenne?

    We also wondered about how you feel issues of informed consent were handled. Some families report that they didn’t feel in hindsight they have been fully aware of what they had agreed to, and would not have consented had they known. Did you feel that this was handled well? As if there was a UK wide programme of screening we would need to ensure that informed consent is properly handled, and families could access the right emotional support.

    Muscular Dystrophy UK staff member

    Alexa Follen
    Keymaster
    Posts: 32
    Joined: 12/05/2015
    #135389
    Reply To: Newborn screening for Duchenne muscular dystrophy

    I completely agree with Chris and Jeanette; my son was thought to have benign hypotonia and by the time he was diagnosed (a couple of months before his 4th birthday) we had been given some therapies that were not appropriate for Duchenne, such as heavy orthopaedic boots. Although the main focus should be on the health and welfare of the boys, I would also not have bought the unadaptable house that I did if I had known he had DMD.

    Penny
    Participant
    Posts: 0
    Joined: 25/07/2016
    #135390
    Reply To: Newborn screening for Duchenne muscular dystrophy

    We would strongly support this. We would say that our consent was done in the ignorance of what DMD was, and we had no knowledge of this condition. Consent was a box that we ticked for the other diseases really- in our ‘Bounty Pack’ which contained descriptions of neonatal diseases that are screened for during pregnancy or post-delivery, DMD was not included. Prior information would be essential to allow proper informed consent.

    Having said that, given the positive result and the immediacy of having to face up to the diagnosis of a little boy who appeared to be physically fine was initially traumatic, but we cannot emphasise enough how the early diagnosis has helped us cope, plan and nurture Alex in the knowledge of his condition.

    The immediate clinical meeting (at the point of diagnosis) was shockingly bad and completely mishandled. This is a common complaint from DMD parents.
    We did have a fantastic social worker who pulled together a team of healthcare professionals who helped us out tremendously. They continue to provide an excellent framework for looking after Alex.

    Chris and Jeanette George
    Participant
    Posts: 0
    Joined: 25/07/2016
    #135396
    Reply To: Newborn screening for Duchenne muscular dystrophy

    I apologise for the delay in responding, I was worried I am only texting to myself, but now a trail of messages have appeared.

    Peter, the international consensus document for steroids indicate that the steroids should be initated at the time of the plateau. This can be already a bit problematic to be assessed anyway, and there is some more recent evidence suggesting that early start leads to better outcome.
    in UK when we did look at the North Star children, the mean age of starting steroids was close to 7, so many children are clearly in the decline phase, certainly not in the plateau phase.
    In our most recent paper on North STar we also clearly demonstrated that those children who did start earlier achieved milestones never achieved by those who were started later. So theer are various argumenst to say that currently steroids are started late too often

    Professor Francesco Muntoni, Director, Dubowitz Neuromuscular Centre, Great Ormond Street Hospital

    Professor Francesco Muntoni
    Participant
    Posts: 0
    Joined: 05/05/2016
    #135397
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Regarding the point made by Francesco, we should say that Alex has been on steroids regime since 4.

    Chris and Jeanette George
    Participant
    Posts: 0
    Joined: 25/07/2016
    #135398
    Reply To: Newborn screening for Duchenne muscular dystrophy

    The main benefit from a newborn screening would be:
    a. early genetic counselling for families
    b. early recognition of specific DMD issues relevant for management.
    c. the access to experimental therapies that are now becoming available for DMD (firs drug ataluren, last week).

    Francesco, on point C, do you think it likely we will see further experimental therapies becoming available that may require a neo-natal diagnosis in order for children to get the maximum benefit?

    As you say, we now have the first approved DMD drug, Translarna, so do you feel it is important that we plan ahead and pilot now? So that should further treatments become available there is no delay in implementing newborn screening.

    Muscular Dystrophy UK staff member

    Alexa Follen
    Keymaster
    Posts: 32
    Joined: 12/05/2015
    #135401
    Reply To: Newborn screening for Duchenne muscular dystrophy

    We would strongly support this. We would say that our consent was done in the ignorance of what DMD was, and we had no knowledge of this condition. Consent was a box that we ticked for the other diseases really- in our ‘Bounty Pack’ which contained descriptions of neonatal diseases that are screened for during pregnancy or post-delivery, DMD was not included. Prior information would be essential to allow proper informed consent.

    Having said that, given the positive result and the immediacy of having to face up to the diagnosis of a little boy who appeared to be physically fine was initially traumatic, but we cannot emphasise enough how the early diagnosis has helped us cope, plan and nurture Alex in the knowledge of his condition.

    The immediate clinical meeting (at the point of diagnosis) was shockingly bad and completely mishandled. This is a common complaint from DMD parents.
    We did have a fantastic social worker who pulled together a team of healthcare professionals who helped us out tremendously. They continue to provide an excellent framework for looking after Alex.

    Thanks – so it sounds like the support you received post diagnosis was really effective? There’s a really strong case for DMD screening, but one concern is that you need to have the Family Care Advisors and other supports in place so people aren’t left to struggle alone. So I wondered what your overall experience was like?

    Muscular Dystrophy UK staff member

    Alexa Follen
    Keymaster
    Posts: 32
    Joined: 12/05/2015
    #135402
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Dear Peter
    as you are aware the current label for ataluren is only for children from the age 5 onwards.
    However PTC has indicated the interest to initate an early trial at least to demonstrate safety in the younger patient population. For drugs that work similarly to ataluren, or antisense, or utrophin upregulation; they protect muscle from damage, so there is no rationale from awaiting to have too much damage before using them. The current label is because the clinical trial, in order to demonstrate efficiacy, focused on a specific range of chidlren to demonstrate efficacy. However , if any drug works when children are 6 or 7 or 9, it will work as well or better when chidlren are younger and they have better presevred musclemass

    Professor Francesco Muntoni, Director, Dubowitz Neuromuscular Centre, Great Ormond Street Hospital

    Professor Francesco Muntoni
    Participant
    Posts: 0
    Joined: 05/05/2016
    #135403
    Reply To: Newborn screening for Duchenne muscular dystrophy

    Just to say that I logged out and in again as the system is a bit clusmsy today and I do not get messages flowing at the usual speed. The system also wish to go on annual leave!

    Professor Francesco Muntoni, Director, Dubowitz Neuromuscular Centre, Great Ormond Street Hospital

    Professor Francesco Muntoni
    Participant
    Posts: 0
    Joined: 05/05/2016
Viewing 20 posts - 1 through 20 (of 42 total)

You must be logged in to reply to this topic.

Keep in touch